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Abstract
Background: During an ascending infection along the reproductive tract, the extra-placental membranes must act
as a selective and competent barrier against pathogens. Human beta defensins (HBD)1, HBD2, and HBD3 are key
elements of innate immunity that are secreted to neutralize/control the progression of infection.
Methods: Full-thickness membranes were mounted on a Transwell device, constituted by two independent
chambers, 1 × 10(6) CFU/ml of Escherichia coli were added to either the amnion (AMN) or the choriodecidual
(CHD) face or to both. Secretion profiles of HBD1, HBD2, and HBD3 to the culture medium were quantified by
ELISA.
Results: In comparison with basal conditions, the secretion profile of HBD1 remained without significant changes;
HBD2 level in CHD and AMN increased 1.9- and 1.4-times, respectively, after stimulation with bacteria. HBD3
secretion level increased significantly (7.8 +/- 1.9 pg/micrograms) in the CHD but only if the stimulus was applied
on the AMN side.
Conclusions: Selective stimulation of extra-placental membranes with E. coli, results in a tissue specific secretion of
HBD1, HBD2, and HBD3 mainly in the CHD, which is the first infected region during an ascending infection.
Background
During normal pregnancy, the fetus grows and develops
in an immunologically privileged environment, part of
this privilege is associated with the intrinsic capacity of
the maternal-fetal interface to respond promptly and
efficiently to any immunological challenge [1]. In this
context, one of the most harmful conditions that strike
against the continuity of pregnancy is the presence of
intrauterine infection, a pathological condition that has
been recognized as a frequent and important mechan-
ism of disease in 30% of all preterm birth [2].
Once the pathogen reaches the uterine cavity, through
an ascending pathway from the cervico-vaginal region,
the extra-placental membranes are positioned critically
between the normally sterile amniotic cavity and the
contaminated extra-uterine environment [3]. These
structures play a key role because their immunological
capacities are directly required to warrant a successful
and sufficient control against pathogens.
Natural antimicrobial peptides, which are essential
components of the innate immune system, provide
broad-spectrum protection against bacteria, yeasts, and
some viruses. These are small, cationic, amphiphilic
petides of 30 to 40 amino acid residues with a molecular
weight of about 3.5-4.5 kDa, encoded by single genes
that comprise highly homologous gene families.
According to their structural differences, defensins are
classified in three major groups: alpha (a), beta (b), and
theta (θ). Beta defensins include human beta defensins
(HBD)1, 2, 3, and 4; they are a major group of antimi-
crobials that are expressed at mucosal surfaces by
epithelial cells and leukocytes that provide the first line
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[4].
Additionally to their antimicrobial actions, HBDs have
been found to have chemoattract properties, suggesting
an interaction between the innate and adaptive immune
sytems [5].
These peptides are expressed throughout the non-
pregnant female reproductive tract and are present in
the vagina, cervix, endometrium, and fallopian tube [6].
During pregnancy, HBDs play a key role in the mechan-
isms to protect maternal and fetal tissues; HBD1-3 are
expressed by placental and chorion trophoblasts, amnion
epithelium, and decidua from term pregnancies [7].
Clinical and experimental evidence indicate that in the
amniotic fluid from women with microbial invasion of
the amniotic cavity (MIAC), HBD2 concentrations are
increased [8]. On the other hand, increased protein
expression of HBD3 has been reported in the fetal
membranes of patients with preterm delivery associated
with chorioamnionitis [7].
The present study was undertaken to evaluate the
secretion of HBD1, HBD2, and HBD-3 on both sides of
membranes after selective stimulation with Escherichia
coli, a highly pathogenic gram-negative bacterium asso-
ciated with preterm delivery and PROM [9], as well as
pregnancy losses [10] and neurological injury in preterm
infants [11]. Besides, when inoculated endocervically in
pregnant rabbits, E. coli elicits a histologic inflammation
in the maternal and fetal compartments [12].
To achieve these goals, we used an ex vivo culture sys-
tem in which the human chorioamniotic membranes
were mounted on Transwell devices, physically separat-
ing the upper and lower chamber. This model allowed
us to reproduce the differential contact between the
amnion (AMN) and the choriodecidua (CHD) regions
and the pathogen and to know the source and secretion
patterns on both sides of the membranes [13,14].
Methods
For this study, nine women were recruited, who under-
went elective cesarean section at term (37-40 weeks of
gestation), with uneventful pregnancies, without evi-
dence of active labor and with neither clinical nor
microbiological signs of chorioamnionitis/lower genital
tract infection. The Internal Review Board of the Insti-
tuto Nacional de Perinatología “Isidro Espinosa de Los
Reyes” in Mexico City (Registry No. 212250-06151)
approved this study, and written informed consent was
obtained from all participants.
General microbiological analyses, including aerobic
and anaerobic microorganisms, were conducted on the
placenta and extra-placental membranes immediately
after delivery, only membranes with proven sterility
were used for this study.
Extra-placental membranes explants culture
Immediately after delivery, the membranes were cut
from the placental disc, placed in a beaker containing
sterile Dulbecco Modified Eagle medium (DMEM);
(Gibco BRL, Bethesda, MD) and transported to the
laboratory. The membranes were washed with 0.9% sal-
ine solution to remove adherent blood clots, segments
representing all zones of the membranes were manually
cut into 18-mm diameter discs and held together with
silicone rubber rings to be placed on the upper chamber
of a Transwell system (CORNING, New York, NY) from
which the original polycarbonate membrane had been
removed previously.
This model has been validated and published pre-
viously by our group [13,14] and reproduced by others
[15]. In this model, the CHD faces the upper chamber
of the Transwell system and the AMN faces the lower
chamber, this allows for the testing of the two indepen-
dent compartments delimited by the membrane. One
milliliter of DMEM supplemented with 10% fetal bovine
serum (FBS), 1 mM sodium pyruvate, and 1X antibiotic-
antimycotic solution (penicillin 100 U/ml, streptomycin
100 μg / m l )( D M E M - F B S )( G i b c oB R L )w e r ea d d e dt o
each side of the chamber.
The mounted explants were placed in a 12-well tissue
culture plate (CORNING, New York, NY) and incubated
in 5% CO2 at 37°C during 24 h to stabilize tissues after
manipulation.
Explants stimulation
On the second day of culture, the explants were washed
with saline solution (0.9% NaCl) to remove FBS. Once
explants had been rinsed, 1 ml of DMEM suplemented
with 0.2% lactalbumin hydrolysate (Gibco BRL), 1 mM
sodium pyruvate and 1X antibiotic-antimycotic solution
was added and co-incubated with 1 × 10
6 CFU Escheri-
chia coli isolated from cervicovaginal exudates.
The inoculum size of 1 × 10
6 CFU has been pre-
viously standardized/published by our group to induce
the secretion of different anti-inflammatory cytokines in
human fetal membranes, as well as by Davies and cols.
(2000) in a rabbit model of acute intra-amniotic infec-
tion [12].
For each experiment (n = 9), the following set of
chambers was included, in triplicate: BASAL, control
membranes in which only the medium culture was
added to both compartments of the chamber; CHORIO-
DECIDUA, the bacterium was added only to the chorio-
decidual compartment; AMNION, the bacterium was
added only to the amnion compartment; BOTH, the
bacterium was added simultaneously to both compart-
ments (CHD and AMN).
After 24 h of co-incubation, the medium from both
compartments of the chambers was collected and
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teria, and the samples were stored at -70°C until
assayed. Protein concentration in all samples was
assessed with the Bradford method [16].
Measurement of HBD1, HBD2, and HBD3 secretion
Concentrations of HBD1, HBD2, and HBD3 were
determined by enzyme-linked immunosorbent sand-
wich assays (ELISA) (Pepro Tech, Rock Hill, NJ). For
the HBD1 assay, a standard curve was developed from
15 to 1000 pg/ml and the sensitivity was 4 pg/ml; for
HBD2, a standard curve was developed from 15 to
1000 pg/ml and the sensitivity was 8 pg/ml; and for
the HBD3 assay, a standard curve was developed from
62.5 to 4000 pg/ml and the sensitivity was 62 pg/ml.
The final concentration of each HBD was expressed
per microgram of the total protein concentration of
each sample.
Statistical analysis
Statistical analysis was performed with the Sigma Stat
2.03 software (Jandel Scientific Software, Chicago, IL).
Statistical significance was determined by one-way
analysis of variance. Tukey’s test was used to assign
individual differences. Where the data failed a normality
test, significance was determined using a Kruskal-Wallis
test. P < 0.05 was regarded as significant.
Results
In comparison to control conditions, selective stimula-
tion with the bacterium did not induce any significant
change in the HBD-1 profile secretion in either CHD or
AMN region (Figure 1).
Under control conditions, the basal secretion of HBD2
was similar in both amniotic and choriodecidual com-
partments, 12.04 (± 5.61) and 8.4 (± 4.19) pg/μgo fp r o -
tein, respectively; after selective stimulation with E. coli
the secretion of HBD2 increased significantly in the
CHD tissue, regardless of whether the bacterium was
applied directly to either the CHD compartment (25.22
±1 . 6 5p g / μg) or the amniotic compartment (28.08 ±
6.18 pg/μg); however, the level secreted of this defensin
by the CHD after simultaneous stimulation rose slightly
but not in a significant way.
On the other hand, the secretion of HBD-2 from
AMN was increased two-fold (16.18 ± 1.65 pg/μg) in
Figure 1 Compartmentalized in vitro secretion of HBD1 in amnion (AMN) and choriodecidua (CHD) regions after selective stimulation
for 24 h with 1 × 10
6 CFU of E. coli. Each bar represents the mean ± SD of 9 different experiments in triplicate. Significant differences
between basal and stimulated conditions are indicated (*P < 0.05).
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lus was applied to the CHD region (Figure 2).
Basal secretion of HBD-3 by the AMN and CHD was
similar (Figure 3), however the secretion by the CHD
tissue showed a 5.4-fold increase (7.87 ± 1.96 pg/μg)
only when the E. coli stimulus was applied directly on
the amnion. Simultaneous stimulation of both sides
induced an increase of 3.0 times in the CHD (4.34 ±
1.41) and of 3.8 times in the amnion (6.15 ± 3.6), how-
ever, none was significant).
Discussion
A rapid and efficient response against any immunologi-
cal/infectious challenge is cr i t i c a lf o ras u c c e s s f u lp r e g -
nancy. When the uterus is invaded by pathogenic
microorganisms through an ascendant pathway from the
lower genital tract, the membranes are strategically posi-
tioned as a highly selective mechanical and immunologi-
cal barrier against the dissemination of infection
between the contaminated intrauterine environment and
the still sterile amniotic cavity.
The experimental model we used in the present study
was designed to emulate the presence of two
compartments separated by a fully functional amnio-
chorion and to replicate the response of extra-placental
membranes to E. coli when added to either the chorio-
decidua or the amnion.
The current study demonstrates that HBD1, HBD2,
and HBD3, found in the choriodecidual or amniotic
compartment after stimulation with the bacterium, were
selectively secreted by these membranes.
Our results demonstrate that the HBD1 secretion pro-
file did not change in either the choriodecidual or the
amnion region of the extra-placental membranes when
stimulated with E. coli.T h i sa g r e e sw i t hp r e v i o u se v i -
dence demonstrating that HBD1 is constitutively
expressed at different surfaces by epithelial cells and leu-
kocytes [4] and is not affected by the presence of
inflammatory mediators [17]; however, there is evidence
that stimulating organotypic epidermal keratinocytes
[18], monocyte and monocytes-derived-macrophages
[19] with LPS upregulated both mRNA and protein of
HBD1.
Presence of mRNA and protein of HBD1 has been
previously reported in the amnion, decidua, and chorion
trophoblast layers, and has been characterized as the
Figure 2 Compartmentalized in vitro secretion of HBD2 in amnion (AMN) and choriodecidua (CHD) regions after selective stimulation
for 24 h with 1 × 10
6 CFU of E. coli. Each bar represents the mean ± SD of 9 different experiments in triplicate. Significant differences
between basal and stimulated conditions are indicated (*P < 0.05).
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during human pregnancy. No obvious difference has
b e e nf o u n di nt h es t a i n i n gp a t t e r no fH B D 1i ne x t r a -
placental membranes from patients, not in labor or in
spontaneous labor, which agrees with the fact that cul-
tured primary placental trophoblast cells do not show
significant change in the mRNA expression of HBD1
when stimulated with IL-1b or LPS [7]. Additionally,
HBD1 has not been associated with pathological condi-
tions, such as premature rupture of membranes
(PROM) and/or chorioamnionitis [6].
On the other hand, there is overwhelming experimen-
tal evidence indicating that HBD2 is an inducible host
defense peptide whose expression, at both the mRNA
and protein levels, is altered under both infectious and
inflammatory conditions. It has been found to be up-re-
gulated by pro-inflammatory stimuli in oral epithelial
cells and keratinocytes [20], in intestinal and colonic
epithelial cell lines [20-22], and in various lung epithelial
cell lines [22,23].
HBD2 is expressed throughout the non-pregnant
female reproductive tract and is present in the vagina,
c e r v i x ,e n d o m e t r i u m ,a n df a l l o p i a nt u b e[ 6 ] .I nt h e
endometrium, peak expresion of HBD2 mRNA coincides
with implantation and menstruation, both key reproduc-
tive events associated with an inflammatory response;
this agrees with the evidence indicating that expression
of HBD2 and HBD3 in endometrial epithelial cells can
be upregulated in response to inflammatory stimuli, sug-
gesting that these defensins will be induced in response
to infection [24].
In the present study, we found that, independently
from whether the bacterium was added only to the
amnion or to the choriodecidua, stimulation with E. coli
elicited high secretion of HBD2 by both compartments,
being the choriodecidua the most reactive tissue. This
supports the concept that extra-placental membranes
have polarity for both stimulus recognition and HBDs
secretion.
During pregnancy, the presence of immunoreactive forms
of HBD2 in the maternal-placental unit has been demo-
strated in the syncytiotrophoblast layer of term placental
villi, the chorion trophoblast layer of term fetal membranes,
as well as in the amnion epithelium and decidua [7].
At the transcription level, HBD2 mRNA expresion of
primary placental trophoblast cells and of primary
Figure 3 Compartmentalized in vitro secretion of HBD3 in amnion (AMN) and choriodecidua (CHD) regions after selective stimulation
for 24 h with 1 × 10
6 CFU of E. coli. Each bar represents the mean ± SD of 9 different experiments in triplicate. Significant differences
between basal and stimulated conditions are indicated (*P < 0.05).
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is not significantly affected; however, treatment with IL-
1b dramatically upregulates this peptide [7].
In a recent study, Soto and cols. [8] demostrated that
within the amniotic fluid from women with MIAC,
HBD2 concentration is increased regardless of the mem-
brane status (intact membranes or PROM). The role of
this peptide within the amniotic cavity has been in part
ascribed to the amnion, which agrees with evidence
indicating that primary amnion epithelial cells in culture
dramatically upregulate HBD2 (mRNA and protein)
after treatment with IL-1b [25].
Our results indicate that when the choriodecidua is
stimulated with E. coli, the concentration of HBD2
within the amniotic compartment increases significantly.
Taking into account that, using the same experimental
model, it was possible to demonstrate that the selective
stimulation of fetal membranes with this bacterium
results in the upregulation of IL-1b being the choriode-
cidual region the most active [14,26], it is feasible to
assume that this pro-inflammatory cytokine might cross
the membrane [27] and reach the opposite side, indu-
cing both synthesis and secretion of this peptide.
This assumption agrees with experimental evidence
demonstrating that the mRNA for IL-1b is only
expressed in the choriodecidua [28] and that secretion
of IL-1b to the amniotic compartment is demonstrable
only when the extra-placental membranes are intact; in
contrast to the experiment in which the amnion and
choriodecidua tissues were mechanically separated,
being the choriodecidua the only one responsive to LPS
and secreting IL-1b in response [13].
Another possibility to explain the apparent coopera-
tive communication between the amnion and the chor-
iodecidua is that being the HBDs polar peptides they
might be part of an active transport across the mem-
branes. Although we know little about the cellular biol-
ogy of HBDs transport across tissues, these can be part
of the paracellular transport, an event that can be modi-
fied by cytokines [29].
However, a puzzling situation emerged when the
secretion of HBD2 was analyzed under simultaneous sti-
mulation of choriodecidua and amnion. We observed no
significant response, this contrasts with the capacities of
the amnion and choriodecidua when stimulated sepa-
rately. A possible explanation is that, under these infec-
tious conditions, which resemble a late stage of
colonization associated with a higher grade of damage,
induction of HBD2 synthesis and secretion was faster
than when the infection was produced separately; there-
fore, the quantification after 24 h did not coincide with
the highest secretion level.
Although less probable, another explanation could be
that counter-regulatory signals were exchanged between
these tissues, resulting in a state of pseudoanergy to E.
coli. The possibility that this situation occurs in vivo is
highly improbable but deserves further investigation.
HBD3 expression and its activity is not well character-
ized; however, our results indicate that, after stimulation
with E. coli, the HBD3 concentration depicted
an increasing trend mainly in the choriodecidual com-
partment; however, this reached significance only when
the amnion was the primary site of contact.
Previous evidence indicates that the choriodecidua is
highly responsive to E. coli [14] and LPS [13] and that,
under these infectious challenges, this region of extra-
placental membranes secretes significant levels of IL-1b
and TNF-a, pro-inflammatory cytokines that up-regu-
late HBD3 at the transcriptional level [30,31].
The secretion of large amounts of TNF-a by mem-
branes under LPS stimulation results from summative
amniochorion secretion, because both tissues can inde-
pendently secrete this cytokine [13]; this evidence agrees
with the results indicating that HBD3 can be induced in
amnion cells in response to bacterial components such
as LPS, a soluble component of the cell wall, which is
responsible for the toxic and pathogenic effect of gram-
negative microorganisms [32].
The current data are consistent with previous studies
that have suggested that HBD3 protein is present in the
amnion of fetal membranes [32] and in placental and
chorion trophoblast layers of fetal membranes and pla-
centa [7].
Chorioamnionitis is widely regarded as an inflamma-
tory event with high levels of proinflammatory cyto-
kines. Previous works have evidenced that inoculation of
the amniotic cavity with E. coli induces a toxic response,
characterized by the overproduction of proinflammatory
cytokines such as IL-1b [26,33], a potent immuno-mod-
ulator able to induce preterm labor after its experimen-
tal infusion in pregnant rhesus monkeys [34].
The present study suggests the existence of a tissue-
specific HBD1, HBD2, and HBD3 secretion pattern as
part of the response to E. coli. These observations have
implications for the understanding of the biologic nature
of innate immunity to establish an efficient/effective
response, which necessarily is related with the capacity
of pathogen recognition.
Toll like receptors (TLRs) are trans-membrane pro-
teins with extracellular domain of leucine-rich repeat
motifs that are evolutionarily conserved to recognize
pathogen-associated molecular patterns (PAMP) in bac-
teria, viruses, fungi, and parasites.
Each TLR differs in its specificity, so while, indivi-
dually, TLRs respond to limited ligands, collectively
the family of TLRs can respond to a wide range of
PAMPs. TLR-4, the first to be identified, is the speci-
fic receptor for gram-negative bacterial LPS and both
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the dominant cell type expressing it is the trophoblast
[35].
The spontaneous labor at term and preterm delivery
with histologic chorioamnionitis, regardless of the mem-
brane status (intact or ruptured), are associated with an
increased expression of TLR-2 and -4 by the chorioam-
niotic membranes [36]. On the other hand, TLR-4
expression in the amnion of preterm infected placenta is
higher than in term non-infected placenta [37].
Conclusions
In the present study we found evidence that the extra-
placental membranes can react differentialy to the arri-
val of E. coli, secreting HBD2 and HBD3 mainly in the
choriodecidua region. The capacity of this region to eli-
cit this innate response has a pathophysiological signifi-
cance because this region is the first to be infected
during an ascending infection.
Differential secretion of antimicrobial peptides is a key
mechanism in the innate immunity to respond efectively
and quickly to control and delimit the progression of
the infection and, eventually, activate the adaptive
immunity.
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